BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rosuvastatin/ezetimibe (Rosuvamibe) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Rosuvastatin/ezetimibe (Rosuvamibe)\, fro
 m ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06767345-8658@assetmemo.bio
DTSTAMP:20261121T005953Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Rosuvastatin/ezetimibe (Rosuvamibe): Phase 4 readout est. (NCT06767
 345)
DESCRIPTION:Rosuvastatin/ezetimibe (Rosuvamibe)\, phase 4\, Atherosclerotic
  Cardiovascular Disease.\nStudy: Comparison of Moderate-Intensity Statin P
 lus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization\
 nEstimated primary completion: November 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/rosuvastatin-ezetimibe-rosuvamibe#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT06767345
URL:https://assetmemo.bio/drug/rosuvastatin-ezetimibe-rosuvamibe#upcoming-e
 vents
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06186037-8658@assetmemo.bio
DTSTAMP:20261121T005953Z
DTSTART;VALUE=DATE:20290228
DTEND;VALUE=DATE:20290301
SUMMARY:Rosuvastatin/ezetimibe (Rosuvamibe): Phase 4 readout est. (NCT06186
 037)
DESCRIPTION:Rosuvastatin/ezetimibe (Rosuvamibe)\, phase 4\, Atherosclerotic
  Cardiovascular Disease.\nStudy: Clinical Comparison of Low-dose Rosuvasta
 tin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monother
 apy in Patients With Minimal to Intermediate Coronary Artery Disease Witho
 ut Percutaneous Coronary Intervention\nEstimated primary completion: 28 Fe
 bruary 2029. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/rosuvast
 atin-ezetimibe-rosuvamibe#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT06186037
URL:https://assetmemo.bio/drug/rosuvastatin-ezetimibe-rosuvamibe#upcoming-e
 vents
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
